Artículos por temáticas
En este apartado encontrará una actualización mensual de artículos sobre la enfermedad de Alzheimer/demencias y sobre los Trastornos del Movimiento clasificados según los 11 tipos establecidos por la International Parkinson & Movement Disorder Society.
FILTRAR POR:
Por tema
164142 ARTíCULOS , VIENDO DEL 98911 AL 98925
Botulinum Toxin in Movement Disorders: An Update
Anandan C, Jankovic J.
Toxins (Basel). 2021 Jan 8;13(1):42. doi: 10.3390/toxins13010042.
0
0
0
Pathogenic mechanism and modeling of neuroferritinopathy
Cozzi A, Santambrogio P, Ripamonti M, Rovida E, Levi S.
Cell Mol Life Sci. 2021 Apr;78(7):3355-3367. doi: 10.1007/s00018-020-03747-w. Epub 2021 Jan 13.
0
0
0
Kim HK, Blumberger DM, Downar J, Daskalakis ZJ.
Clin Neurophysiol. 2021 Feb;132(2):429-448. doi: 10.1016/j.clinph.2020.11.025. Epub 2020 Dec 16.
0
0
0
Movement disorders in 2020: clinical trials, genetic discoveries, and COVID-19
Tan EK.
Lancet Neurol. 2021 Jan;20(1):10-12. doi: 10.1016/S1474-4422(20)30448-8.
0
0
0
Tics in patients with encephalitis
Badenoch J, Searle T, Watson I, Cavanna AE.
Neurol Sci. 2021 Apr;42(4):1311-1323. doi: 10.1007/s10072-021-05065-w. Epub 2021 Jan 23.
0
0
0
Quetiapine treatment for cannabis use disorder
Mariani JJ, Pavlicova M, Jean Choi C, Basaraba C, Carpenter KM, Mahony AL, Brooks DJ, Bisaga A, Naqvi N, Nunes EV, Levin FR.
Drug Alcohol Depend. 2021 Jan 1;218:108366. doi: 10.1016/j.drugalcdep.2020.108366. Epub 2020 Oct 20.
0
0
0
Exome-wide rare variant analysis in familial essential tremor
Diez-Fairen M, Houle G, Ortega-Cubero S, Bandres-Ciga S, Alvarez I, Carcel M, Ibañez L, Fernandez MV, Budde JP, Trotta JR, Tonda R, Chong JX, Bamshad MJ, Nickerson DA; University of Washington Center
Parkinsonism Relat Disord. 2021 Jan;82:109-116. doi: 10.1016/j.parkreldis.2020.11.021. Epub 2020 Nov 24.
0
0
0
Risk of Hospitalization and Death for COVID-19 in People with Parkinson's Disease or Parkinsonism
Vignatelli L, Zenesini C, Belotti LMB, Baldin E, Bonavina G, Calandra-Buonaura G, Cortelli P, Descovich C, Fabbri G, Giannini G, Guarino M, Pantieri R, Samoggia G, Scaglione C, Trombetti S, D'Alessand
Mov Disord. 2021 Jan;36(1):1-10. doi: 10.1002/mds.28408. Epub 2020 Dec 2.
0
0
0
Electroconvulsive Therapy for Parkinson's Disease: A Systematic Review and Meta-Analysis
Takamiya A, Seki M, Kudo S, Yoshizaki T, Nakahara J, Mimura M, Kishimoto T.
Mov Disord. 2021 Jan;36(1):50-58. doi: 10.1002/mds.28335. Epub 2020 Oct 14.
0
0
0
Multiple café-au-lait macules and movement disorder: think beyond neurofibromatosis
Madaan P, Mukherjee S, Reddy C, Yadav J, Saini L.
Arch Dis Child. 2021 Jan;106(1):73. doi: 10.1136/archdischild-2019-317497. Epub 2019 Jul 27.
0
0
0
Patil S, Tas V.
2021 Jul 21. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan–.
0
0
0
Zergham AS, Chauhan Z.
2020 Jun 9. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan–.
0
0
0
A Two-to-Five Year Follow-Up of a Pediatric Acute-Onset Neuropsychiatric Syndrome Cohort
Gromark C, Hesselmark E, Djupedal IG, Silverberg M, Horne A, Harris RA, Serlachius E, Mataix-Cols D.
Child Psychiatry Hum Dev. 2021 Feb 9:1-11. doi: 10.1007/s10578-021-01135-4. Online ahead of print.
0
0
0
Non-epileptic paroxysmal events in paediatric patients: A single tertiary centre study in Egypt
Thabit MN, Sadek AA, Motawe ES, Ali RAE, Mohamed MM.
Seizure. 2021 Mar;86:123-128. doi: 10.1016/j.seizure.2021.02.004. Epub 2021 Feb 10.
0
0
0
MYD88 signals induce tumour-initiating cell generation through the NF-κB-HIF-1α activation cascade
Tanimura A, Nakazato A, Tanaka N.
Sci Rep. 2021 Feb 17;11(1):3991. doi: 10.1038/s41598-021-83603-4.
0
0
0
Comentarios
En ningún caso la información facilitada constituye asesoramiento por parte de Zambon
Con el aval de:
En colaboración con:
